Back to Results

BioLargo Inc (BLGO)

BioLargo Inc. is a common stock listing on OTC Markets under the symbol BLGO. The company develops and commercializes platform technologies in the United States with a focus on environmental and related applications. Its work addresses PFAS water contamination, water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and environmental remediation. BioLargo also provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. The company is based in Westminster, California.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-BLGO
$0.094
1.6% Upside
Fair
$0.30
224.3% Upside
Bargain
Weak
0.0%
November 18, 2026
7.4x
30.408 M
33.571 M
17.9%
85.9%
-41.8
72.9%
Valuation • Fair Value

BioLargo Inc (OTC-BLGO) Fair Value by Valuation Model

Review the available estimates for BioLargo Inc (OTC-BLGO), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.094

Estimated upside of 1.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.091

Discounted cash flow valuation reference.

Comps Fair Value

$0.096

Comparable-company valuation reference.

Analyst Price Target

$0.30

Analysts imply upside of 224.3%.

How to read these valuation models

Use the 5 available valuation references for BioLargo Inc (OTC-BLGO) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for BioLargo Inc (OTC-BLGO)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

4.082 M

Current operating scale indicator.

Revenue Forecast

5.229 M

Forward revenue estimate.

EBITDA

-17.951 M

Current operating profitability reference.

EBITDA Forecast

-12.279 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review BioLargo Inc (OTC-BLGO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for BioLargo Inc (OTC-BLGO)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

0

Weak quality score that deserves closer review.

Beneish M-Score

-6.74

No elevated caution signal from this screen.

Altman Z-Score

-41.8

Lower score that deserves closer risk review.

FCF / Net Income

72.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for BioLargo Inc (OTC-BLGO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for BioLargo Inc (OTC-BLGO)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 18, 2026

Days to Earnings

57

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for BioLargo Inc (OTC-BLGO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

BioLargo Inc (OTC-BLGO) Stock Forecast & Technical Outlook

Review BioLargo Inc (OTC-BLGO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for BioLargo Inc (OTC-BLGO) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for BioLargo Inc (OTC-BLGO) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for BioLargo Inc (OTC-BLGO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, BioLargo Inc (OTC-BLGO) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

BioLargo Inc (OTC-BLGO) Stock FAQ

Data-supported answers about BioLargo Inc (OTC-BLGO), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.094
Estimated upside 1.6%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$0.30
Implied upside 224.3%
Financial Health
Weak
Current financial-health read

The current fair value estimate for BioLargo Inc (OTC-BLGO) is $0.094. This implies an estimated upside of 1.6% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for BioLargo Inc (OTC-BLGO) is $0.30. The analyst target implies estimated upside of 224.3%.

The current financial health read for BioLargo Inc (OTC-BLGO) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for BioLargo Inc (OTC-BLGO) is November 18, 2026.

The latest available data indicates no current dividend yield for BioLargo Inc (OTC-BLGO).

The current market capitalization listed for BioLargo Inc is 30.408 M.

The current enterprise value listed for BioLargo Inc is 33.571 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for BioLargo Inc is OTC-BLGO, and the stock is listed on OTC Markets.

BioLargo Inc (OTC-BLGO) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for BioLargo Inc is 17.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for BioLargo Inc is 85.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Chemicals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LIN NASDAQ Linde PLC Fair Value Fair Market Cap 214.3 B
SHW NYSE Sherwin-Williams Co Fair Value Fair Market Cap 79.241 B
ECL NYSE Ecolab Inc Fair Value Fair Market Cap 77.432 B
APD NYSE Air Products and Chemicals Inc Fair Value Fair Market Cap 64.102 B
CTVA NYSE Corteva Inc Fair Value Fair Market Cap 53.603 B
NTR NYSE Nutrien Ltd Fair Value Fair Market Cap 36.041 B
PPG NYSE PPG Industries Inc Fair Value Fair Market Cap 23.957 B
IFF NYSE International Flavors & Fragrances Inc Fair Value Fair Market Cap 21.889 B
DOW NYSE Dow Inc Fair Value Fair Market Cap 20.37 B
SQM NYSE Sociedad Quimica y Minera de Chile SA ADR B Fair Value Undervalued Market Cap 20.049 B
LYB NYSE LyondellBasell Industries NV Fair Value Undervalued Market Cap 19.137 B
CF NYSE CF Industries Holdings Inc Fair Value Fair Market Cap 18.25 B
DD NYSE Dupont De Nemours Inc Fair Value Fair Market Cap 17.799 B
ALB NYSE Albemarle Corp Fair Value Undervalued Market Cap 13.783 B
RPM NYSE RPM International Inc Fair Value Fair Market Cap 12.906 B
SOLS NASDAQ Solstice Advanced Materials Inc Fair Value Fair Market Cap 9.355 B
WLK NYSE Westlake Chemical Corporation Fair Value Fair Market Cap 8.792 B
SSL NYSE Sasol Ltd Fair Value Undervalued Market Cap 8.644 B
ESI NYSE Element Solutions Inc Fair Value Overvalued Market Cap 8.575 B
NEU NYSE NewMarket Corporation Fair Value Fair Market Cap 8.174 B